ask="N/A"
ask_size="N/A"
average_daily_volume="22890"
bid="N/A"
bid_size="N/A"
book_value="0.45"
change="N/A"
change_from_200_day_moving_average="0.33"
change_from_50_day_moving_average="0.35"
change_from_52_week_high="-1.24"
change_From_52_week_low="2.28"
change_in_percent="N/A"
close="4.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-14.69M"
eps_estimate_current_year="-1.69"
eps_estimate_next_quarter="-0.02"
eps_estimate_next_year="-0.25"
ex_dividend_date="N/A"
float_shares="4889000"
high="N/A"
high_52_weeks="5.29"
last_trade_date="2/13/2017"
last_trade_price="4.05"
last_trade_size="N/A"
last_trade_time="4:02pm"
low="N/A"
low_52_weeks="1.77"
market_capitalization="61.29M"
moving_average_200_day="3.72"
moving_average_50_day="3.70"
name="NovaBay Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.75"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+8.89%"
percent_change_from_50_day_moving_average="+9.50%"
percent_change_from_52_week_high="-23.44%"
percent_change_from_52_week_low="+128.81%"
previous_close="4.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.96"
price_per_sales="6.48"
revenue="9.45M"
shares_outstanding="15134000"
short_ratio="6.33"
stock_exchange="ASE"
symbol="NBY"
volume="0"
weeks_range_52="1.77 - 5.29"
